Hemangiopericytoma (HPC) is a rare tumour, it represents 2-3% of malignant soft tissue tumours in all locations combined, due to its rarity, and no codified guidelines. The confirmatory diagnosis is histological. The standard treatment is surgery. The course after treatment is characterized by the frequency of recurrences and distant metastases, requiring extended follow-up.
We report the observation of a patient with a right nasal hemangiopericytoma whose evolution was known by a local relapse 6 years later with a review of the literature.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
